Premium
Divergent effects of peroxisome proliferator–activated receptor‐γ ligands in human and mouse nonalcoholic steatohepatitis
Author(s) -
Caldwell Stephen H.,
Argo Curtis K.
Publication year - 2007
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.21881
Subject(s) - thiazolidinedione , troglitazone , steatohepatitis , endocrinology , medicine , pioglitazone , rosiglitazone , steatosis , insulin resistance , fatty liver , lipotoxicity , nonalcoholic fatty liver disease , biology , type 2 diabetes , peroxisome proliferator activated receptor , insulin , diabetes mellitus , receptor , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom